152 related articles for article (PubMed ID: 16680932)
1. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis.
Ohashi Y; Nakai Y; Murata K
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):600-5. PubMed ID: 16680932
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis.
Ngamphaiboon J; Direkwattanachai C; Visitsunthorn N; Vangveeravong M; Tiensuwan M
Asian Pac J Allergy Immunol; 2005 Dec; 23(4):169-74. PubMed ID: 16572735
[TBL] [Abstract][Full Text] [Related]
3. A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis.
Bunnag C; Jareoncharsri P; Tunsuriyawong P; Pumhirun P; Limprasertsiri S; Chochaipanichnon L; Supiyaphun P; Kongpatanakul S
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):127-33. PubMed ID: 11270466
[TBL] [Abstract][Full Text] [Related]
4. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
Meltzer EO; Casale TB; Nathan RA; Thompson AK
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge.
Lanier BQ; Abelson MB; Berger WE; Granet DB; D'Arienzo PA; Spangler DL; Kägi MK
Clin Ther; 2002 Jul; 24(7):1161-74. PubMed ID: 12182260
[TBL] [Abstract][Full Text] [Related]
6. Effect of fexofenadine hydrochloride on cedar pollinosis.
Miyabe S; Koizuka I; Ochi K; Tanaka K; Kuroda H; Takatsu M; Kinoshita H; Sugiyama Y
Auris Nasus Larynx; 2003 Feb; 30 Suppl():S61-8. PubMed ID: 12543163
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Milgrom H; Kittner B; Lanier R; Hampel FC
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):358-63. PubMed ID: 17941284
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
[TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
12. Specific immunotherapy is effective in the prevention of new sensitivities.
Reha CM; Ebru A
Allergol Immunopathol (Madr); 2007; 35(2):44-51. PubMed ID: 17428399
[TBL] [Abstract][Full Text] [Related]
13. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.
Okubo K; Gotoh M; Shimada K; Ritsu M; Okuda M; Crawford B
Int Arch Allergy Immunol; 2005 Feb; 136(2):148-54. PubMed ID: 15650312
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
Segall N; Grubbe RE; Levy AL; Maloney MJ; Nayak AS; Kittner B; Quesada JT
Allergy Asthma Proc; 2008; 29(4):380-5. PubMed ID: 18702885
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber.
Yamamoto H; Yonekura S; Sakurai D; Katada K; Inamine A; Hanazawa T; Horiguchi S; Okamoto Y
Allergy Asthma Proc; 2012; 33(5):397-403. PubMed ID: 23026181
[TBL] [Abstract][Full Text] [Related]
17. H1-antihistaminic activity of cetirizine and fexofenadine in allergic children.
Simons FE; J Semus M; Goritz SS; Simons KJ
Pediatr Allergy Immunol; 2003 Jun; 14(3):207-11. PubMed ID: 12787300
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Spangler DL; Abelson MB; Ober A; Gotnes PJ
Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
[TBL] [Abstract][Full Text] [Related]
20. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
